US President Trump announced plans to raise pharmaceutical import tariffs from a “small” initial rate to 150 per cent, and eventually 250 per cent, aiming to boost domestic production within 18 months ...

How would you like to have a company in your portfolio that not only has no pressure of interest payments due its zero debt ...

Rigel (RIGL) delivered earnings and revenue surprises of +66.50% and +28.99%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?